General Information of Drug (ID: DMZ57Q0)

Drug Name
CTP-692
Synonyms Deutarserine; D-serine-2-d; Deutarserine [USAN]; UNII-OD54L0MH86; OD54L0MH86; SCHEMBL10901499; WHO 11514; (2R)-2-amino-2-deuterio-3-hydroxypropanoic acid; C-21692; 103292-62-2
Indication
Disease Entry ICD 11 Status REF
Schizophrenia 6A20 Phase 2 [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
Chemical Identifiers
Formula
C3H7NO3
Canonical SMILES
C(C(C(=O)O)N)O
InChI
1S/C3H7NO3/c4-2(1-5)3(6)7/h2,5H,1,4H2,(H,6,7)/t2-/m1/s1/i2D
InChIKey
MTCFGRXMJLQNBG-LIIDHCAMSA-N
Cross-matching ID
PubChem CID
12219623
CAS Number
103292-62-2
TTD ID
DC52UD

References

1 ClinicalTrials.gov (NCT04158687) A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-692 as an Adjunctive Treatment in Adults With Schizophrenia. U.S. National Institutes of Health.